President Donald Trump has signed an executive order to promote domestic pharmaceutical manufacturing in the US. The order includes measures to simplify the process for foreign pharmaceutical companies to build new facilities in the US and to increase inspection fees and regulations for pharmaceuticals imported from overseas. Additionally, Trump signed an order prohibiting federal funding for ‘Gain-of-function’ research, which studies mutant viruses and has been linked to the ‘COVID-19 China origin theory’.
Original Article: Read More
Auto-posted at: 2025-05-06 09:05:38